Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04724759 · ClinicalTrials.gov registry record · Phase 2
The Effect of Opioid-Free Anesthesia in TMJ Surgery
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT04724759: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT04724759 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04724759, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims is to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing oral and maxillofacial surgery (OMF) temporomandibular joint (TMJ) surgery.
Interventions
- DRUG Dexmedetomidine / Ketamine / Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-18 |
| Est. Completion | 2023-04-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04724759
The ClinicalTrials.gov registry entry for NCT04724759 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine / Ketamine / Lidocaine is the first listed.
NCT04724759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04724759 about?
NCT04724759 is a clinical study titled "The Effect of Opioid-Free Anesthesia in TMJ Surgery". This study aims is to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing oral and maxillofacial surgery (OMF) temporomandibular joint (TMJ) surgery.
What is the current status of trial NCT04724759?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-06-18. Estimated completion is 2023-04-23.
What interventions are being tested in trial NCT04724759?
The interventions under investigation include: Dexmedetomidine / Ketamine / Lidocaine (DRUG).
Who is sponsoring clinical trial NCT04724759?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.